Nasacort and Nasonex are both allergy nasal sprays that contain drugs called corticosteroids. With allergies, the body’s immune system responds to an allergen, or trigger. This causes symptoms such as ...

KENILWORTH, N.J., July 17 Schering-PloughCorporation (NYSE: SGP) today announced that Schering-Plough K.K., thecompany's country operation in Japan, has received marketing approval forNASONEX(R) ...

DUBLIN, March 17, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the U.S.

Schering-Plough reported that the FDA has approved a new scent-free formulation of Nasonex prescription nasal inhaled steroid. Nasonex remains the first and only once-daily prescription nasal inhaled ...

With spring allergies in the air, two prescription-products-gone-over-the-counter recently – Astepro and Nasonex -- have sprung creative campaigns. Surrounded by flowers, and clothed and posed as if ...

Schering-Plough's successful allergy medication gets an updated ad campaign. The Nasonex Bee is buzzing a new tune. Schering-Plough is working with BBDO to update its successful Nasonex (mometasone ...

The FDA’s Division of Drug Marketing, Advertising and Communications has issued untitled letters of violation to Schering-Plough for its Nasonex nasal spray, and to GlaxoSmithKline for its Flonase ...

WHITEHOUSE STATION, N.J. — Merck announced that the U.S. District Court for the District of New Jersey ruled against the company in a patent infringement suit against Canada-based drug maker Apotex.

Le Nasonex® est un traitement corticoïde qui exerce une activité anti-inflammatoire au niveau de la muqueuse nasale. Ce médicament produit par le laboratoire MSD France est disponible à la vente ...

June 15 (Reuters) - Merck & Co, Inc lost a patent infringement lawsuit against Apotex Inc on Friday over Apotex's plans to market a generic version of the nasal allergy spray Nasonex. Sign up here.